Trials / Completed
CompletedNCT04238728
Silverlon to Reduce Radiation Dermatitis
An Unblinded, Open-label Study Evaluating the Safety of Silverlon to Manage Radiation Dermatitis.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- Female
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if a silver-nylon dressing (Silverlon®, Argentum Medical) is useful for the prevention or treatment of radiation dermatitis in patients receiving radiation therapy to the breast.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Silverlon | silver nylon dressing will be applied daily |
Timeline
- Start date
- 2020-08-31
- Primary completion
- 2022-03-01
- Completion
- 2022-03-25
- First posted
- 2020-01-23
- Last updated
- 2024-01-05
- Results posted
- 2024-01-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04238728. Inclusion in this directory is not an endorsement.